Topic

Isomorphic Labs

Isomorphic Labs Announces $2.1B Funding to Scale its AI Drug Design Engine

Insider Brief PRESS RELEASE — Isomorphic Labs, an AI-first drug design and development company, has announced it has raised $2.1 Billion in Series B funding. This latest round of investment will accelerate the company’s

13 May 2026 · 5 min read

Business & Markets

Isomorphic Labs Announces $600M Funding to Further Develop its Next-generation AI Drug Design Engine and Advance Therapeutic Programs into the Clinic

31 Mar 2025

Business & Markets · Enterprise

Isomorphic Labs Founder Sees AI-Designed Drug Entering Trials by Year-End

22 Jan 2025

Technology & Infrastructure

Google DeepMind Researchers Say AlphaFold 3 Represents a New Era in Molecular Biology And Drug Discovery

9 May 2024

Technology & Infrastructure

Isomorphic Labs Announces Strategic Multi-Target Research Collaboration With Novartis

8 Jan 2024

Isomorphic Labs

Isomorphic Labs Announces $2.1B Funding to Scale its AI Drug Design Engine

Isomorphic Labs Announces $600M Funding to Further Develop its Next-generation AI Drug Design Engine and Advance Therapeutic Programs into the Clinic

Isomorphic Labs Founder Sees AI-Designed Drug Entering Trials by Year-End

Google DeepMind Researchers Say AlphaFold 3 Represents a New Era in Molecular Biology And Drug Discovery

Isomorphic Labs Announces Strategic Multi-Target Research Collaboration With Novartis

Trending today

Archer’s Boeing Subsidiary Deal Moves Closer to Closing, Expanding Physical AI Push in Aerospace

Greek PM Mitsotakis Pitches Greece to Silicon Valley While Admitting AI Leaves Governments Unprepared

Ando Emerges From Stealth With $20M to Build a Messaging Platform for Humans and AI Agents

Japan’s O-ID Raises $1.2M in Pre-Seed Funding to Develop Modular Humanoid Robots for Factories

Lovable Passes $600M in Annual Run-Rate Revenue as Enterprise Adoption Grows

Isomorphic Labs

Isomorphic Labs Announces $2.1B Funding to Scale its AI Drug Design Engine

Isomorphic Labs Announces $600M Funding to Further Develop its Next-generation AI Drug Design Engine and Advance Therapeutic Programs into the Clinic

Isomorphic Labs Founder Sees AI-Designed Drug Entering Trials by Year-End

Google DeepMind Researchers Say AlphaFold 3 Represents a New Era in Molecular Biology And Drug Discovery

Isomorphic Labs Announces Strategic Multi-Target Research Collaboration With Novartis

Trending today

Archer’s Boeing Subsidiary Deal Moves Closer to Closing, Expanding Physical AI Push in Aerospace

Greek PM Mitsotakis Pitches Greece to Silicon Valley While Admitting AI Leaves Governments Unprepared

Ando Emerges From Stealth With $20M to Build a Messaging Platform for Humans and AI Agents

Japan’s O-ID Raises $1.2M in Pre-Seed Funding to Develop Modular Humanoid Robots for Factories

Lovable Passes $600M in Annual Run-Rate Revenue as Enterprise Adoption Grows

The AI economy, every weekday morning